X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Recognizing Hepatitis R&D on World Hepatitis Day

By Andrew Powaleny  |    July 28, 2021
Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, with types A, B, C most common. In 2018, the Centers for Disease...   Read More

We Work for Health: Discovering champions, even amid challenging times

By Ryan Garofalo  |    July 26, 2021
For over a decade, We Work For Health has sought to highlight the incredible men and women who create hope for patients, serve as changemakers and ensure the continued vibrancy of our economy. We...   Read More

PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020

By Tim McClung  |    July 22, 2021
PhRMA member companies’ robust investment in research and development (R&D) has led to advances and discoveries that are transforming health care and our approach to treating patients for a broad...   Read More

3 things that support robust biopharmaceutical research and development

By Richard Moscicki, M.D.  |    June 29, 2021
Rapid advances in scientific discovery have ushered in a new era of medicine, transforming our ability to treat, and in some cases cure, many of the most challenging diseases, including cancer,...   Read More

Watch: Building trust and enhancing clinical trial diversity

By Andrew Powaleny  |    June 24, 2021
On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA Chief Operating Officer Lori Reilly and Genentech Vice President and Chief...   Read More

IP Explained: How does the U.S. patent process work?

By Megan Van Etten  |    June 24, 2021
Have you ever used a Teflon-coated pan or hit a golf ball down the fairway? Had a friend or family member receive treatment with a new medication? All these products were developed because patents...   Read More

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US

By Stephen J. Ubl  |    June 23, 2021
Our industry continues to work tirelessly to combat the COVID-19 virus by developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. As we continue our efforts...   Read More

More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities

By Andrew Powaleny  |    June 22, 2021
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients,...   Read More

Researchers to shine light on biopharmaceutical R&D with policymakers

By Andrew Powaleny  |    June 15, 2021
Today, biopharmaceutical researchers from PhRMA member companies are meeting virtually with members of Congress and staff to share their stories of transforming game-changing scientific...   Read More

How research evolves and brings new hope to patients

By Stephen J. Ubl  |    June 11, 2021
Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body....   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates